Congress trades in Genprex (GNPX)

Healthcare · Biotechnology

1 member of Congress has disclosed 4 trades in Genprex (GNPX) since 2025: 4 buys and 0 sales. The most recent was disclosed on Feb 23, 2026.

Trades disclosed: 4
Members trading: 1
Buys / sells: 4 / 0
Reported value: $18K–$95K

Who traded GNPX

MemberBuysSalesLast disclosed

Rep. Tim Moore (R-NC-14)4 buys · 0 sales40Feb 23, 2026

All trades

DisclosedTradeAmount

Feb 23, 2026
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Feb 5, 2026 · disclosed Feb 23, 2026
$1K–$15K
Jan 8, 2026
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 8, 2026
$1K–$15K
Dec 3, 2025
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$1K–$15K · Traded Nov 7, 2025 · disclosed Dec 3, 2025
$1K–$15K
Nov 12, 2025
Rep. Tim Moore (R-NC-14)
Bought Genprex GNPX
$15K–$50K · Traded Oct 29, 2025 · disclosed Nov 12, 2025
$15K–$50K

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.